Primary Myelofibrosis - 26 Studies Found
Completed |
: A Phase 2 Study With IPI-926 in Patients With Myelofibrosis :
: 2011-06-09 : Drug: IPI-926 Single Arm study of oral IPI-926 at 160 mg, 130 mg or 110 mg daily, until progressive dise |
Completed |
: Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis :
: 2011-01-18 |
Completed |
: Ph II Study of Azacitidine in Myelofibrosis : Myelofibrosis : 2007-12-06 : Drug: Azacitidine 75 mg/m^2 subcutaneous daily for 7 days (every 4 week cycle) |
Recruiting |
: Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis :
|
Active, not recruiting |
: Study of Ruxolitinib for Patients With Myelofibrosis (MF) : Myelofibrosis : 2016-05-20 :
|
RECRUITING |
: Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis : Primary Myelofibrosis : 2024-05-14 : Experimental |